The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
Open accessAbstract
Diabetes is a complex metabolic syndrome that is characterized by prolonged high blood glucose levels and frequently associated with life-threatening complications 1,2. Epidemiological studies have suggested that diabetes is also linked to an increased risk of cancer 3-5. High glucose levels may be a prevailing factor that contributes to the link between diabetes and cancer, but little is known about the molecular basis of this link and how the high glucose state may drive genetic and/or epigenetic alterations that result in a cancer phenotype. Here we show that hyperglycaemic conditions have an adverse effect on the DNA 5-hydroxymethylome. We identify the tumour suppressor TET2 as a substrate of the AMP-activated kinase (AMPK), which phosphorylates TET2 at serine 99, thereby stabilizing the tumour suppressor. Increased glucose levels impede AMPK-mediated phosphorylation at serine 99, which results in the destabilization of TET2 followed by dysregulation of both 5-hydroxymethylcytosine (5hmC) and the tumour suppressive function of TET2 in vitro and in vivo. Treatment with the anti-diabetic drug metformin protects AMPK-mediated phosphorylation of serine 99, thereby increasing TET2 stability and 5hmC levels. These findings define a novel 'phospho-switch' that regulates TET2 stability and a regulatory pathway that links glucose and AMPK to TET2 and 5hmC, which connects diabetes to cancer. Our data also unravel an epigenetic pathway by which metformin mediates tumour suppression. Thus, this study presents a new model for how a pernicious environment can directly reprogram the epigenome towards an oncogenic state, offering a potential strategy for cancer prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“this could represent a case of reverse causation, as hyperglycemia might influence the development or expansion of clones by interfering with TET2 function 90”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Self-citationAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
Self-citationA decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
He, Y., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,776
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Self-citationLong-Term Complications of Diabetes Mellitus
Nathan, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282306 · Cited by 1,495
Cited by
Sorted by citations
Items 101–200 of 476
DNA Methylation in Cancer: Epigenetic View of Dietary and Lifestyle Factors
Maleknia, M., Ahmadirad, N., Golab, F., Katebi, Y., & Ketabforoush, A. H. M. E. (2023) · Epigenetics Insights · doi:10.1177/25168657231199893 · Cited by 43
Spatial control of AMPK signaling at subcellular compartments
Chauhan, A. S., Li, Z., & Gan, B. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1727840 · Cited by 41
Ma, Z.-Z., Wang, Y.-S., Liu, B., Jiao, H., & Xu, L. F. (2022) · Chemosensors · doi:10.3390/chemosensors10100416 · Cited by 38
Zhang, L., Zhai, B.-Z., Wu, Y., & Wang, Y. (2023) · Drug Delivery · doi:10.1080/10717544.2022.2144541 · Cited by 39
AMPK: An odyssey of a metabolic regulator, a tumor suppressor, and now a contextual oncogene
Penugurti, V., Mishra, Y. G., & Manavathi, B. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188785 · Cited by 39
TET2 facilitates PPARγ agonist–mediated gene regulation and insulin sensitization in adipocytes
Bian, F., Ma, X., Villivalam, S. D., You, D., Choy, L. R., Paladugu, A., Fung, S., & Kang, S. (2018) · Metabolism · doi:10.1016/j.metabol.2018.08.006 · Cited by 38
Zhao, P., & Malik, S. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00821-7 · Cited by 37
The Role of AMPK Signaling in Ulcerative Colitis
Yuan, Y., Wang, F., Liu, X., Shuai, B., & Fan, H. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s442154 · Cited by 38
Wang, F., Weng, Z., Lyu, Y., Bao, Y., Liu, J., Zhang, Y., Sui, X., Fang, Y., Tang, X., & Shen, X. (2020) · Food & Function · doi:10.1039/d0fo01229g · Cited by 37
Li, N., Zheng, X. Y., Chen, M., Huang, L., Chen, L., Huo, R., Li, X., Huang, Y., Sun, M., Mai, S., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1386 · Cited by 38
Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation
Jacquel, A., Luciano, F., Robert, G., & Auberger, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102991 · Cited by 37
Interplay between Clonal Hematopoiesis of Indeterminate Potential and Metabolism
Lee, M. K. S., Dragoljevic, D., Veiga, C. B., Wang, N., Yvan‐Charvet, L., & Murphy, A. J. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.02.005 · Cited by 37
Zhang, M., Chen, X., & Radacsi, N. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.047 · Cited by 36
Li, H., Li, C., Zhang, B., & Jiang, H. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03983-1 · Cited by 35
Shu, W., Zheng, H., Fu, X., Zhen, J., Tan, M., Xu, J., Zhao, X., Yang, S., Song, H., & Ma, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165752 · Cited by 35
The metabolic-epigenetic nexus in type 2 diabetes mellitus
Davison, G. W., Irwin, R. E., & Walsh, C. P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.025 · Cited by 35
Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
Stein, A., Metzeler, K. H., Kubasch, A. S., Rommel, K., Desch, S., Buttner, P. G., Rosołowski, M., Cross, M. A., Platzbecker, U., & Thiele, H. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00969-w · Cited by 40
Intrauterine exposure to hyperglycemia retards the development of brown adipose tissue
Yu, D., Lv, P., Yan, Y., Xu, G., Sadhukhan, A., Dong, S., Shen, Y., Ren, J. T., Zhang, X., Feng, C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801818r · Cited by 34
Gao, Z., Lv, H., Wang, Y., Xie, Y., Guan, M., & Xu, Y. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00757-9 · Cited by 36
Chen, J., Jiao, D., Li, Y., Jiang, C., Tang, X., Song, J., & Chen, Q. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009619666190619154240 · Cited by 34
Li, T., Fang, T., Xu, L., Liu, X., Li, X., Xue, M., Yu, X., Sun, B., & Chen, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.622153 · Cited by 34
A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis
Ji, Y., Wang, Y., Li, P.-L., Cai, L., Wang, X., Bai, L., Liu, Z., Tian, H., Tian, S., Zhang, P., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.006 · Cited by 34
Paternal Nongenetic Intergenerational Transmission of Metabolic Disease Risk
Su, L., & Patti, M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1163-0 · Cited by 35
Chen, X., Wang, H., Wu, C. F., Li, X., Huang, X., Ren, Y., Pu, Q., Cao, Z., Tang, X., & Ding, B. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103038 · Cited by 33
Kundu, A., Shelar, S. B., Ghosh, A. P., Ballestas, M. E., Kirkman, R. L., Nam, H., Brinkley, G. J., Karki, S., Mobley, J. A., Bae, S., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011089 · Cited by 34
Li, A. M., & Ye, J. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-120857 · Cited by 31
Metformin protects against mouse oocyte apoptosis defects induced by arecoline
Li, W., Zang, C., Yin, S., Shen, W., Sun, Q., & Zhao, M. (2020) · Cell Proliferation · doi:10.1111/cpr.12809 · Cited by 31
TETology: Epigenetic Mastermind in Action
Seethy, A. A., Pethusamy, K., Chattopadhyay, I., Sah, R., Chopra, A., Dhar, R., & Karmakar, S. (2021) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-021-03537-5 · Cited by 31
Zhang, T., He, Q., Liu, Y., Chen, Z., & Hu, H.-J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/4471944 · Cited by 32
The hepatic AMPK-TET1-SIRT1 axis regulates glucose homeostasis
Zhang, C., Zhong, T., Li, Y., Li, X., Yuan, X., Liu, L., Wu, W., Wu, J., Wu, Y., Liang, R., et al. (2021) · eLife · doi:10.7554/elife.70672 · Cited by 32
Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis
Egan, G., & Schimmer, A. D. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.11.004 · Cited by 35
From the (Epi)Genome to Metabolism and Vice Versa; Examples from Hematologic Malignancy
Karagianni, P., Giannouli, S., & Voulgarelis, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126321 · Cited by 35
Pharmacological effect and mechanism of orlistat in anti-tumor therapy: A review
Hao, X., Zhu, X., Tian, H., Lai, G., Zhang, W., Zhou, H., & Liu, S. (2023) · Medicine · doi:10.1097/md.0000000000034671 · Cited by 30
TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression
Bonvin, E., Radaelli, E., Bizet, M., Luciani, F., Calonne, E., Putmans, P., Nittner, D., Singh, N. K., Santagostino, S. F., Petit, V., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1214 · Cited by 30
Tanaka, Y., Konishi, A., Obinata, H., & Tsuneoka, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-55075-0 · Cited by 31
Drug delivery for metabolism targeted cancer immunotherapy
Khodaei, T., Inamdar, S., Suresh, A. P., & Acharya, A. P. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114242 · Cited by 30
Chen, L., He, X., Wang, H., Fang, J., Zhang, Z., Zhu, X., Qi, Z., Guo, Y., Liu, R., & Li, D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123288 · Cited by 29
Kalantri, S., & Vora, A. (2024) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2024.2345131 · Cited by 31
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review
Papa, V., Marracino, L., Fortini, F., Rizzo, P., Campo, G. C., Vaccarezza, M., & Sega, F. V. D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082480 · Cited by 29
A high-performance Co-MOF non-enzymatic electrochemical sensor for glucose detection
Ma, Z.-Z., Ma, Y., Liu, B., Xu, L. F., & Jiao, H. (2021) · New Journal of Chemistry · doi:10.1039/d1nj04480j · Cited by 29
He, X., Pei, S., Meng, X., Hua, Q., Zhang, T., Wang, Y., Zhang, Z., Zhu, X., Liu, R., Guo, Y., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00863 · Cited by 31
Byun, S., Lee, C. H., Jeong, H., Kim, H., Kwon, H. M., Park, S. H., Myung, K., An, J., & Ko, M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205626119 · Cited by 31
Guo, B., Hou, X., Zhang, Y., Deng, Z., Qian, P., Fu, K., Yuan, Z., & Rao, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.985826 · Cited by 28
5-Hydroxymethylcytosine: Far Beyond the Intermediate of DNA Demethylation
Zheng, K., Lyu, Z., Chen, J., & Chen, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111780 · Cited by 29
Hu, M., Zhang, C., Liang, L., Wang, S., Zheng, X., Zhang, Q., Jiang, C., Zhong, Q., & Huang, F. (2019) · Head & Neck · doi:10.1002/hed.25691 · Cited by 29
Zhang, J., Zhao, K., Zhou, W., Kang, R., Wei, S., Shu, Y., Cheng, Y., Ku, Y., Mao, Y., Luo, H., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01778-4 · Cited by 30
Xin, J., Shu, C., Fu, Y., Yu, X., Wang, Z., Zeng, X., Wang, R., Meng, T., Sun, J. Q., & Yan, M. (2024) · Talanta · doi:10.1016/j.talanta.2024.127152 · Cited by 27
Chen, Y., Huang, C., Shi, Y., Lee, Y., Wang, L., & Chang, L. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.09.008 · Cited by 27
Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity
Menéndez, J. A. (2020) · Biomolecules · doi:10.3390/biom10050780 · Cited by 27
Yang, Q., Yu, B., Kang, J., Li, A., & Sun, J. (2021) · Cancer Management and Research · doi:10.2147/cmar.s303707 · Cited by 27
Integration of epigenetic regulatory mechanisms in heart failure
Sopić, M., Robinson, E. L., Emanueli, C., Srivastava, P. K., Angione, C., Gaetano, C., Condorelli, G., Martelli, F., Pedrazzini, T., Devaux, Y., et al. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-00986-3 · Cited by 28
Andersson‐Assarsson, J. C., van Deuren, R. C., Kristensson, F. M., Steehouwer, M., Sjöholm, K., Svensson, P., Pieterse, M., Gilissen, C., Taube, M., Jacobson, P., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104621 · Cited by 27
Decourcelle, A., Leprince, D., & Dehennaut, V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00117 · Cited by 25
Hu, X., Wu, J., Xiong, H., Zeng, L., Wang, Z., Wang, C., Huang, D., Zhang, T., Peng, Y., Chen, W., et al. (2021) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13244 · Cited by 25
PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen
Tinsley, S. L., & Allen-Petersen, B. L. (2022) · NAR Cancer · doi:10.1093/narcan/zcac002 · Cited by 26
Metformin combats obesity by targeting FTO in an m 6 A-YTHDF2-dependent manner
Liao, X., Liu, J., Chen, Y., Liu, Y., Chen, W., Zeng, B., Liu, Y., Luo, Y., Huang, C., Guo, G., et al. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2071906 · Cited by 27
Overexpression of NNMT in Glioma Aggravates Tumor Cell Progression: An Emerging Therapeutic Target
Sun, W., Zou, Y., Cai, Z., Huang, J., Hong, X., Liang, Q., & Jin, W. (2022) · Cancers · doi:10.3390/cancers14143538 · Cited by 25
Loss of TET2 impairs endothelial angiogenesis via downregulating STAT3 target genes
Shi, Y., Li, B., Huang, X., Kou, W., Zhai, M., Zeng, Y., You, S., Yu, Q., Zhao, Y., Zhuang, J., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00960-5 · Cited by 24
TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential
He, J., Lin, M., Zhang, X., Zhang, R., Tian, T., Zhou, Y., Dong, W., Yang, Y., Sun, X., Dai, Y., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00567-7 · Cited by 27
Malagoli, C., Malavolti, M., Farnetani, F., Longo, C., Filippini, T., Pellacani, G., & Vinceti, M. (2019) · Nutrients · doi:10.3390/nu11092206 · Cited by 24
Zhang, T., He, Q., Liu, Y. Z., Chen, Z., & Hu, H.-J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5644171 · Cited by 24
Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk
Haring, B., Wissel, S., & Manson, J. E. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01724-2 · Cited by 29
The “sweet” path to cancer: focus on cellular glucose metabolism
Iacobini, C., Vitale, M., Pugliese, G., & Menini, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1202093 · Cited by 23
Recent progress in quantitative phosphoproteomics
Zittlau, K. I., Nashier, P., Cavarischia-Rega, C., Maček, B., Spät, P., & Nalpas, N. (2023) · Expert Review of Proteomics · doi:10.1080/14789450.2023.2295872 · Cited by 24
Restoration of TET2 deficiency inhibits tumor growth in head neck squamous cell carcinoma
Huang, R., Wang, Y., Ge, H., Wang, D., Wang, Y., Zhang, W., Yang, J., & Cheng, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.145 · Cited by 23
Epigenetics and environmental health
Zhang, M., Hu, T., Ma, T., Huang, W., & Wang, Y. (2024) · Frontiers of Medicine · doi:10.1007/s11684-023-1038-2 · Cited by 29
Zhao, Z., Lan, M., Li, J., Dong, Q., Li, X., Liu, B., Li, G., Wang, H., Zhang, Z., & Zhu, B. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006255 · Cited by 23
Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology
Cuyàs, E., Verdura, S., Martı́n-Castillo, B., & Menéndez, J. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.620641 · Cited by 23
DNA methylation and regulation of DNA methyltransferases in a freeze-tolerant vertebrate
Zhang, J., Hawkins, L. J., & Storey, K. B. (2019) · Biochemistry and Cell Biology · doi:10.1139/bcb-2019-0091 · Cited by 24
Kato, J., Shirakami, Y., Ohnishi, M., Mizutani, T., Kubota, M., Sakai, H., Ibuka, T., Tanaka, T., & Shimizu, M. (2019) · Oncology Reports · doi:10.3892/or.2019.7357 · Cited by 23
Immunometabolism in atherosclerotic disorders
Fleetwood, A. J., Noonan, J. E., Gruta, N. L. L., Kallies, A., & Murphy, A. J. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00473-5 · Cited by 28
Zhang, L., Li, Q., Wang, H., Wu, Y., Ye, X., Gong, Z., Li, Q., & Xuan, A. (2022) · Stem Cells · doi:10.1093/stmcls/sxab001 · Cited by 21
Type-2 diabetes mellitus-associated cancer risk: In pursuit of understanding the possible link
Vulichi, S. R., Runthala, A., Nagaraju, B., Kumar, R., Chunduri, V. R., Kapur, S., Chippada, A. R., & Sistla, D. S. M. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102591 · Cited by 23
Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy
Jung, I., An, J., & Ko, M. (2023) · Biomedicines · doi:10.3390/biomedicines11030654 · Cited by 22
Wołowiec, A., Wołowiec, Ł., Grześk, G., Jaśniak, A., Osiak, J., Husejko, J., & Kozakiewicz, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813723 · Cited by 23
Liu, P., Shuaib, M., Zhang, H., Nadeef, S., & Orlando, V. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0322-5 · Cited by 23
Specific regulation of epigenome landscape by metabolic enzymes and metabolites
Yu, X., & Li, S. (2024) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13049 · Cited by 24
Li, M., Lu, J., Fu, J., Wan, Q., Wang, T., Huo, Y., Xu, Y., Xu, M., Zhao, Z., Chen, Y., et al. (2020) · PubMed Central · Cited by 21
Hassan, H. M., Isovic, M., Kolendowski, B., Bauer-Maison, N., Onabote, O., Cecchini, M. J., Haig, A. R., Vareki, S. M., Underhill, T. M., & Torchia, J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.039 · Cited by 22
Green, H. L. H., & Brewer, A. C. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00848-y · Cited by 21
Wang, Y., Sun, C., Huang, L., Liu, M., Li, L., Wang, X., Wang, L., Sun, S., Xu, H., Ma, G., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121509 · Cited by 19
Causes of Clonal Hematopoiesis: a Review
Joo, L., Bradley, C. C., Lin, S. H., Scheet, P. A., & Nead, K. T. (2023) · Current Oncology Reports · doi:10.1007/s11912-023-01362-z · Cited by 23
Rao, V. K., Adusumalli, S., Tham, G.-H., Lin, W., Han, B., Benoukraf, T., Xu, G., & Ong, C. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1144 · Cited by 21
Clonal Hematopoiesis and Premalignant DiseasesPreprint
Kaner, J. D., Desai, P. M., Mencia-Trinchant, N., Guzmán, M. L., Roboz, G. J., & Hassane, D. C. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035675 · Cited by 20
Keramida, K., López‐Fernández, T., Anker, M. S., Petrie, M. C., Ameri, P., Anderson, L. J., Bergler-Klein, J. K., Deswal, A. M., Farmakis, D. T., Ibáñez, B., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.70005 · Cited by 21
Effects of diabetes on the development of radiation pneumonitis
Dong, G., Li, Y., Zhao, Q., Pang, B., Qi, X., Wei, J., & Hou, W. (2021) · Respiratory Research · doi:10.1186/s12931-021-01754-4 · Cited by 19
Hyperglycemia induces gastric carcinoma proliferation and migration via the Pin1/BRD4 pathway
Yu, J., Hu, D., Wang, L., Fan, Z., Xu, C., Lin, Y., Chen, X., Lin, J., & Peng, F. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01030-4 · Cited by 19
Li, C., Kuang, J., Zhao, Y., Sun, H., & Guan, H. (2020) · Endocrine · doi:10.1007/s12020-020-02291-8 · Cited by 19
Fang, Y., Li, F., Qi, C., Mao, X., Wang, F., Zhao, Z., Chen, J., Zhang, Z., & Wu, H. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0285-0 · Cited by 19
Downregulation of 5‐hydroxymethylcytosine is an early event in pancreatic tumorigenesis
Fujikura, K., Alruwaii, Z. I., Haffner, M. C., Trujillo, M. A. M., Roberts, N. J., Hong, S., Macgregor‐Das, A. M., Goggins, M., Roy, S., Meeker, A. K., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5682 · Cited by 19
Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes
Dhawan, P., Vasishta, S., Balakrishnan, A., & Joshi, M. B. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120490 · Cited by 18
Arnold, P. R., Wen, M., Zhang, L., Ying, Y., Xiao, X., Chu, X., Wang, G., Zhang, X., Mao, Z., Zhang, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.966364 · Cited by 16
Metformin: A Promising Antidiabetic Medication for Cancer Treatment
Mu, W., Jiang, Y., Liang, G., Feng, Y., & Qu, F. (2022) · Current Drug Targets · doi:10.2174/1389450124666221104094918 · Cited by 18
Tseng, Y.-J., Kageyama, Y., Murdaugh, R. L., Kitano, A., Kim, J. H., Hoegenauer, K. A., Tiessen, J., Smith, M. H., Uryu, H., Takahashi, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44718-0 · Cited by 21
AMPK Regulates the Epigenome through Phosphorylation of TET2
Fiedler, E. C., & Shaw, R. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.015 · Cited by 18
Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
Marini, C., Cossu, V., Bauckneht, M., Lanfranchi, F., Raffa, S., Orengo, A. M., Ravera, S., Bruno, S., & Sambuceti, G. (2021) · Biomolecules · doi:10.3390/biom11081231 · Cited by 18
Engelhardt, B. G., Savani, U. B., Jung, D. K., Powers, A. C., Jagasia, M., Chen, H., Winnick, J. J., Tamboli, R. A., Crowe, J. E., & Abumrad, N. N. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.02.001 · Cited by 18
Epigenetic Therapies in Melanoma—Targeting DNA Methylation and Histone Modification
Țigu, A. B., Ivancuta, A., Uhl, A., Sabo, A. C., Nistor, M., Mureșan, X. M., Cenariu, D., Timis, T., Diculescu, D. M., & Gulei, D. (2025) · Biomedicines · doi:10.3390/biomedicines13051188 · Cited by 17
The role of glycometabolic plasticity in cancer
Peng, Y., Yang, H., & Li, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153595 · Cited by 17
Loos, J. A., Coccimiglio, M., Nicolao, M. C., Rodrígues, C. R., & Cumino, A. C. (2021) · Parasitology · doi:10.1017/s0031182021001633 · Cited by 17
Metadata
- Authors
- Wu, D., Hu, D., Chen, H., Shi, G., Fetahu, I. S., Wu, F., Rabidou, K., Fang, R., Tan, L., Xu, S., Liu, H., Argueta, C., Zhang, L., Mao, F., Yan, G., Chen, J., Dong, Z., Lv, R., Xu, Y., Wang, M., Ye, Y., Zhang, S., Duquette, D., Geng, S., Yin, C., Lian, C. G., Murphy, G. F., Adler, G. K., Garg, R., Lynch, L., Yang, P., Li, Y., Lan, F., Fan, J., Shi, Y., & Shi, Y. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Shanghai Medical College of Fudan University (CN)
- Fudan University (CN)
- Corresponding author
- Shi, Yang
- Shi, Yujiang Geno
- ORCID
- Venue
- Nature
- Published
- 2018-07
- Volume
- 559
- Issue
- 7715
- Pages
- 637-641
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6430198
- OpenAlex
- W2884558319
- Cited by
- 477
- References
- 33
- Citations by year
- 2026: 39 · 2025: 48 · 2024: 56 · 2023: 64 · 2022: 71 · 2021: 67 · 2020: 55 · 2019: 55 · 2018: 22
- FWCI
- 17.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (CA194302)
- National Heart, Lung, and Blood Institute (T32HL007609, K24HL103845)
- National Cancer Institute (R01CA194302)
- National Institute of General Medical Sciences (R01GM112062)
- National Institute of Allergy and Infectious Diseases (R01AI134861)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- TET2, AMPK, hyperglycemia, diabetes mellitus, cancer, 5-hydroxymethylcytosine, DNA demethylation, protein phosphorylation, protein stability, metformin, tumor suppression, epigenetic reprogramming
- MeSH terms
- Adenylate Kinase, Animals, Diabetes Mellitus, DNA, DNA-Binding Proteins, Enzyme Stability, Glucose, Glycated Hemoglobin, Humans, Hyperglycemia, Metformin, Mice, Nude, Neoplasms, Phosphorylation, Phosphoserine, Proto-Oncogene Proteins, Substrate Specificity, DNA Methylation, Xenograft Model Antitumor Assays, Epigenesis, Genetic, 5-Methylcytosine, Dioxygenases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review